AB Science S.A. (OTCMKTS:ABSCF) Short Interest Down 99.3% in June

AB Science S.A. (OTCMKTS:ABSCF) was the recipient of a large drop in short interest in June. As of June 15th, there was short interest totaling 1,000 shares, a drop of 99.3% from the May 31st total of 140,570 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ? days.

AB Science Price Performance

Shares of OTCMKTS ABSCF opened at $1.12 on Friday. The firm’s 50-day moving average is $1.17 and its two-hundred day moving average is $1.34. AB Science has a 12-month low of $1.12 and a 12-month high of $1.37.

AB Science Company Profile

AB Science is a clinical-stage biotechnology company headquartered in Paris, France, specializing in the discovery and development of protein kinase inhibitors. Its core focus is on the design of orally administered small-molecule therapies that target key signaling pathways involved in oncology, inflammatory disorders and neurodegenerative diseases. The company’s lead asset, masitinib, is a selective tyrosine kinase inhibitor that has been evaluated in multiple Phase 2 and Phase 3 clinical trials, including studies in mastocytosis, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease and severe asthma.

Since its founding in 2001 by Dr.